EFCC ARRAIGNS MAN FOR ALLEGED ₦55M FRAUD IN LAGOS. (PHOTO). #PRESS RELEASE.

Image
 EFCC Arraigns Man  for  Alleged ₦55m Fraud in Lagos The Lagos Zonal Directorate 1 of the Economic and Financial Crimes Commission, EFCC, on Wednesday, December 3, 2025 arraigned one Gabriel Celestine Nwawuzor, before Justice Daniel Osiagor of the Federal High Court in Ikoyi, Lagos for ₦55m fraud. Nwawuzor was arraigned alongside Moonlink Pharmaceuticals Limited, on a 3-count charge bordering on fraud and money laundering to the tune of N55,000,000 (Fifty Five Million Naira) One of the counts reads: "That you Gabriel Celestine Nwawuzor and Moonlink Pharmaceuticals Limited sometime in April, 2021, in Lagos, within the jurisdiction of this Honorable Court procured the account number 2170235882 domiciled in Zenith Bank to retain the sum of N55, 000, 000.00 ( Fifty Five Million Naira) which sum you knew forms part of the proceeds of your unlawful act and you thereby committed an offence contrary to Sections 21(a), 18(2)(d) of the of Money Laundering (Prevention and Prohibitio...

TEXAS AND FLORIDA MOVE TO JOIN LAWSUIT CHALLENGING ABORTION PILL. (PHOTO).


 Texas and Florida move to join lawsuit challenging abortion pill

Texas and Florida on Friday requested permission from a federal judge to join a lawsuit aimed at limiting access to the abortion pill mifepristone, arguing they must protect their own abortion policies amid shifting laws in other Republican-led states.

The case is currently spearheaded by Missouri, Kansas, and Idaho, which claim the U.S. Food and Drug Administration improperly eased restrictions on mifepristone, including allowing remote prescriptions and mail delivery. Texas and Florida contend in a court filing that the existing states may no longer fully represent the interests of all Republican-led states. They cited legal changes that have affected Missouri and Idaho’s bans on elective abortions, as well as a Kansas Supreme Court decision affirming broad abortion rights, which they say weaken the original plaintiffs’ position. The states also said they need to defend their policies against “shield laws” in other states, such as New York, that facilitate mail-order access to the drug.

The lawsuit challenges FDA actions from 2016 and 2021 that expanded the window for medication abortions from seven to ten weeks of pregnancy and permitted mailing the drug without an in-person clinician visit. The case began under former President Joe Biden and has been defended by the Trump administration, with the Supreme Court rejecting attempts last year to further restrict Mifepristone. A federal judge allowed Missouri, Kansas, and Idaho to continue the case, paving the way for Texas and Florida’s request to join.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.